HTA194 Impact of the Introduction of the NICE Severity Modifier on HTA Outcomes of Oncology and Non-oncology Orphan Drugs
Abstract
Authors
Hafsa Hersi Catherine Ann Dutton Michael Tang
Hafsa Hersi Catherine Ann Dutton Michael Tang
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now